DataMeds AI Inc.
Common Stock · NASDAQ
Live TMS charts are coming soon.
Paper trading. Simulated, no real money.
No public theses on MEDS yet. When TMS traders open paper trades on it and make their thesis public, the long and short split, average conviction and hit rate show here.
Key stats load once market data is connected.
An Investing.com piece argues AI is changing drug discovery and names four stocks it sees as positioned to benefit: ANT, MEDS, RXRX and SDGR. The headline alone gives no company-specific facts or figures.
No SEC financials for MEDS yet. Companies that file 10-K and 10-Q reports show revenue, earnings, cash flow and the balance sheet here.
Source: SEC filings (10-K, 10-Q).
Paper trading only. Nothing here is financial advice.